View Item 

Show simple item record

Progression and treatment of incident lower urinary tract symptoms ( LUTS ) among men in the C alifornia M en's H ealth S tudy

dc.contributor.authorWallner, Lauren P.en_US
dc.contributor.authorSlezak, Jeff M.en_US
dc.contributor.authorLoo, Ronald K.en_US
dc.contributor.authorQuinn, Virginia P.en_US
dc.contributor.authorVan Den Eeden, Stephen K.en_US
dc.contributor.authorJacobsen, Steven J.en_US
dc.date.accessioned2015-01-07T15:24:43Z
dc.date.available2016-03-02T19:36:56Zen
dc.date.issued2015-01en_US
dc.identifier.citationWallner, Lauren P.; Slezak, Jeff M.; Loo, Ronald K.; Quinn, Virginia P.; Van Den Eeden, Stephen K.; Jacobsen, Steven J. (2015). "Progression and treatment of incident lower urinary tract symptoms ( LUTS ) among men in the C alifornia M en's H ealth S tudy." BJU International (1): 127-133.en_US
dc.identifier.issn1464-4096en_US
dc.identifier.issn1464-410Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110063
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherLower Urinary Tract Symptomsen_US
dc.subject.otherProgressionen_US
dc.subject.otherIncidenceen_US
dc.subject.otherBenign Prostatic Hyperplasiaen_US
dc.titleProgression and treatment of incident lower urinary tract symptoms ( LUTS ) among men in the C alifornia M en's H ealth S tudyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110063/1/bju12810.pdf
dc.identifier.doi10.1111/bju.12810en_US
dc.identifier.sourceBJU Internationalen_US
dc.identifier.citedreferenceSarma AV, Jacobsen SJ, Girman CJ et al. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men. J Urol 2002; 168: 1446 – 1452en_US
dc.identifier.citedreferenceJacobsen SJ, Girman CJ, Guess HA, Rhodes T, Oesterling JE, Lieber MM. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol 1996; 155: 595 – 600en_US
dc.identifier.citedreferenceParsons JK, Wilt TJ, Wang PY, Barrett‐Connor E, Bauer DC, Marshall LM. Progression of lower urinary tract symptoms in older men: a community based study. J Urol 2010; 183: 1915 – 1920en_US
dc.identifier.citedreferenceMartin S, Lange K, Haren MT, Taylor AW, Wittert G. Risk factors for progression and improvement of lower urinary tract symptoms (LUTS) in a prospective cohort of men. J Urol 2013; 191: 130 – 137en_US
dc.identifier.citedreferenceMcConnell JD, Roehrborn CG, Bautista OM et al. The long‐term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387 – 2398en_US
dc.identifier.citedreferenceRoehrborn CG. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2‐year placebo‐controlled study. BJU Int 2006; 97: 734 – 741en_US
dc.identifier.citedreferenceRoehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF‐ONE. BJU Int 2008; 101 ( Suppl. 3 ): 17 – 21en_US
dc.identifier.citedreferenceEnger SM, Van den Eeden SK, Sternfeld B et al. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health 2006; 6: 172en_US
dc.identifier.citedreferenceFlick E, Habel LA, Chan KA et al. Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 2218 – 2225en_US
dc.identifier.citedreferenceHaque R, Van Den Eeden SK, Jacobsen SJ et al. Correlates of prostate‐specific antigen testing in a large multiethnic cohort. Am J Manag Care 2009; 15: 793 – 799en_US
dc.identifier.citedreferenceBarry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. the Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549 – 1557; discussion 1564en_US
dc.identifier.citedreferenceRoehrborn CG, Siami P, Barkin J et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2‐year results from the CombAT study. J Urol 2008; 179: 616 – 621; discussion 621en_US
dc.identifier.citedreferenceVan Den Eeden SK, Shan J, Jacobsen SJ et al. Evaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol 2012; 187: 185 – 189en_US
dc.identifier.citedreferenceSarma AV, Wei JT, Jacobson DJ et al. Comparison of lower urinary tract symptom severity and associated bother between community‐dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology 2003; 61: 1086 – 1091en_US
dc.identifier.citedreferenceSarma AV, Wallner L, Jacobsen SJ, Dunn RL, Wei JT. Health seeking behavior for lower urinary tract symptoms in black men. J Urol 2008; 180: 227 – 232en_US
dc.identifier.citedreferenceSexton CC, Coyne KS, Kopp ZS et al. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int 2009; 103 ( Suppl. 3 ): 12 – 23en_US
dc.identifier.citedreferenceJacobsen SJ, Guess HA, Panser L et al. A population‐based study of health care‐seeking behavior for treatment of urinary symptoms. the Olmsted County Study of Urinary Symptoms and Health Status among Men. Arch Fam Med 1993; 2: 729 – 735en_US
dc.identifier.citedreferenceRoberts RO, Rhodes T, Panser LA et al. Natural history of prostatism: worry and embarrassment from urinary symptoms and health care‐seeking behavior. Urology 1994; 43: 621 – 628en_US
dc.identifier.citedreferenceShaw C. A review of the psychosocial predictors of help‐seeking behaviour and impact on quality of life in people with urinary incontinence. J Clin Nurs 2001; 10: 15 – 24en_US
dc.identifier.citedreferenceShaw C, Tansey R, Jackson C, Hyde C, Allan R. Barriers to help seeking in people with urinary symptoms. Fam Pract 2001; 18: 48 – 52en_US
dc.identifier.citedreferenceBrown CT,. Yap T, Cromwell DA et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ 2007; 334: 25en_US
dc.identifier.citedreferenceBrown CT, van der Meulen J, Mundy AR, O'Flynn E, Emberton E. Defining the components of a self‐management programme for men with uncomplicated lower urinary tract symptoms: a consensus approach. Eur Urol 2004; 46: 254 – 262; discussion 63en_US
dc.identifier.citedreferenceLitwin MS, Saigal CS, Beerbohm EM. The burden of urologic diseases in America. J Urol 2005; 173: 1065 – 1066en_US
dc.identifier.citedreferenceStothers L, Thom D, Calhoun E. Urologic diseases in America project: urinary incontinence in males–demographics and economic burden. J Urol 2005; 173: 1302 – 1308en_US
dc.identifier.citedreferenceWelch G, Weinger K, Barry MJ. Quality‐of‐life impact of lower urinary tract symptom severity: results from the Health Professionals Follow‐up Study. Urology 2002; 59: 245 – 250en_US
dc.identifier.citedreferenceGirman CJ, Epstein RS, Jacobsen SJ et al. Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology 1994; 44: 825 – 831en_US
dc.identifier.citedreferenceSaigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol 2005; 173: 1309 – 1313en_US
dc.identifier.citedreferenceWei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173: 1256 – 1261en_US
dc.identifier.citedreferencePlatz EA, Joshu CE, Mondul AM, Peskoe SB, Willett WC, Giovannucci E. Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men. J Urol 2012; 188: 496 – 501en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bju12810.pdf
Size:
190.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.